PRD-001

N/A

Report date: 2026/02/09 20:01:27
NMEFirst In Class

Base Information

Drug NamePRD-001
Drug Alias NamePRD001PRD-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase 2 inhibitorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase 2Proprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPRD Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPRD Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A